Protein Ingredients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The protein ingredients market size was valued at USD 28.32 billion in 2025 and estimated to grow from USD 29.77 billion in 2026 to reach USD 38.21 billion by 2031, at a CAGR of 5.12% during the forecast period (2026-2031). This report is Segmented by Source (Animal, Plant, Microbial, Insect), Form (Concentrates, Isolates, Textured/Hydrolyzed), Application (Food & Beverage, Animal Feed, Personal Care and Cosmetics, and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Both Value (USD) and Volume (Units).

Global Protein Ingredients Market Trends and Insights

Growing Consumer Preference for Ready-to-Drink Protein Beverages

The global market shows an increase in ready-to-drink (RTD) beverage launches with protein content, driving suppliers to develop isolates with improved solubility and heat stability for acidic, shelf-stable products. Precision-fermentation technology allows manufacturers to produce casein and whey alternatives that match dairy functionality without cold-chain requirements. This development has shifted procurement focus from commodity costs to bio-identical performance capabilities. The growth in beverages requires protein manufacturers to create refined, specialized hydrolyzed forms that offer better dispersibility with minimal flavor impact. For instance, companies such as Future Cow are investing in precision fermentation to produce bioidentical milk proteins through yeast fermentation, providing dairy functionality without traditional supply limitations. These technological advancements have made processing compatibility and functional performance key factors in ingredient selection.

Growing Production of Plant-based Meat

Advances in plant-based meat production are fundamentally transforming protein extraction and texturization processes across the global food manufacturing industry. Advanced seed-breeding techniques have yielded peas with 75% protein content, significantly reducing processing requirements and energy consumption throughout the entire manufacturing chain. Major agricultural companies are strategically adapting their business models by investing heavily in alternative protein production facilities, research and development, and innovative technologies. Cargill's February 2024 expansion of its partnership with ENOUGH aims to increase mycoprotein production to over 1 million tons by 2033, highlighting the substantial shift in production capabilities and market demand. The rapid growth of plant-based meat has also influenced regulatory frameworks and compliance requirements, as evidenced by the FDA's revised guidelines for protein quality assessment, which extend beyond the traditional PDCAAS (Protein Digestibility-Corrected Amino Acid Score) method to evaluate complex new protein combinations, formulations, and nutritional profiles in alternative meat products.

Stringent Regulatory Environment

The regulatory approval process for novel protein ingredients presents significant market entry barriers, as approval timelines frequently extend beyond standard product development cycles, benefiting established companies. The European Food Safety Authority's (EFSA) 2025 guidelines require comprehensive documentation for toxicity testing, allergenicity assessments, and detailed production strain analysis, including genetic stability data and metabolic characterization, increasing barriers and giving advantages to companies with in-house regulatory expertise. For insect protein manufacturers, the regulatory landscape is particularly complex, requiring simultaneous compliance with both novel food regulations and animal feed approval processes across multiple jurisdictions. including the EU's Novel Food Regulation, the FDA's GRAS notification system, and various Asia-Pacific regulatory frameworks. This complex regulatory environment drives market consolidation, favoring companies that possess established regulatory expertise and sufficient financial resources to manage extensive documentation requirements and multi-year approval processes.

Other drivers and restraints analyzed in the detailed report include:

• Rising Demand for Nutritional, Fortified and Functional Foods
• Increasing Demand for Sports Nutrition
• Growing Allergen Concerns

Segment Analysis

Plant proteins dominated with 63.52% of protein ingredients market revenue in 2025, supported by European Union approval for high-yield aquatic crops like duckweed in February 2025, which achieves 43% protein content.This significant market share reflects increasing consumer demand for plant-based alternatives and substantial investments in production infrastructure. The plant-based protein ingredients market is expected to grow steadily through 2031, driven by new large-scale fractionation facilities in North America and Europe, enhanced processing technologies, and expanding applications across food and beverage sectors. Microbial proteins, while an emerging segment, are growing at a 6.29% CAGR, benefiting from CO₂-fed fermentation systems that minimize land and water usage while improving sustainability metrics. These innovative production methods are attracting significant research and development investment from major food manufacturers.

The industry is evolving toward sophisticated hybrid protein formulations that combine plant, microbial, and select animal-source proteins to optimize nutrition, functionality, and cost. These blends address specific market needs across various applications, from sports nutrition to meat alternatives. While dairy-derived whey and casein proteins remain important in applications requiring complete amino-acid profiles and established supply chains, their market share is decreasing as alternative proteins gain regulatory approval and demonstrate improved functionality. Insect proteins represent a small but significant segment, with mealworm approvals in pet food applications creating potential pathways for future human food applications. The segment is experiencing increased investment in production facilities and research into extraction methods.

Complete Report Scope:

• By Source
  • Animal Protein
    • Dairy Ingredients
      • Whey Protein Concentrates
      • Whey Protein Hydrolysates
      • Whey Protein Isolates
      • Casein and Caseinates
    • Egg Protein
    • Gelatin and Collagen
    • Other Animal Proteins
  • Plant Proteins
    • Soy
    • Pea
    • Wheat
    • Rice
    • Potato
    • Hemp
    • Others
  • Microbial Proteins
    • Mycoprotein
    • Algea Protein
  • Insect Protein
• By Form
  • Concentrates
  • Isolates
  • Textured/Hydrolyzed
• By Application
  • Food and Beverage
    • Bakery and Confectionery
    • Meat Analogs and Extenders
    • Dairy Alternatives
    • Savoury Snacks and Bars
    • Beverages
    • Infant and Early-Life Nutrition
  • Dietary Supplements and Sports Nutrition
  • Animal Feed
  • Personal Care and Cosmetics
  • Pharmaceuticals and Clinical Nutrition
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America accounts for 29.10% of 2025 revenue, influencing global specifications through its advanced dairy processing and biotechnology infrastructure. The region's sophisticated processing facilities, research institutions, and established supply networks create an ecosystem that sets industry standards. The United States and Canada are expanding capacity through significant investments in plant protein extraction facilities and precision fermentation technologies, while efficient regulatory frameworks facilitate new product introductions across multiple protein categories.

Europe maintains growth through favorable novel food policies and consumer adoption of sustainable diets. The region's comprehensive regulatory framework and streamlined approval process has accelerated the commercialization of alternative proteins. Insect farming operations, algae cultivation facilities, and mycelium-based protein production centers are scaling up operations, with mainstream retailers incorporating these ingredients into an expanding range of private-label products.

The Middle East and Africa region demonstrates the highest growth at 6.41% CAGR, supported by government-backed diversification initiatives. Saudi Arabia's USD 70 million investment in single-cell protein technology encompasses research facilities, production infrastructure, and workforce development programs. The UAE's agricultural land-lease programs in Africa include technology transfer agreements, logistics partnerships, and market access provisions. These initiatives reduce import reliance and establish export-oriented protein ingredient production centers with integrated value chains.

List of Companies Covered in this Report:

• Archer Daniels Midland Company
• Cargill Incorporated
• Kerry Group plc
• Roquette Freres
• Fonterra Co-operative Group Ltd.
• FrieslandCampina Ingredients
• Glanbia plc
• DuPont de Nemours, Inc. (IFF Nourish)
• BASF SE
• Ingredion Incorporated
• Darling Ingredients Inc.
• CP Kelco
• Axiom Foods Inc.
• Burcon NutraScience Corp.
• Tate and Lyle PLC
• MycoTechnology Inc.
• Calysta Inc.
• NOW Foods
• AMCO Protein
• Kewpie Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support